Clopidogrel resistance "Live" - the risk of stent thrombosis should be evaluated before procedures

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F09%3A00001937" target="_blank" >RIV/00216208:11120/09:00001937 - isvavai.cz</a>

Alternative codes found

RIV/00023736:_____/09:00008484

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Clopidogrel resistance "Live" - the risk of stent thrombosis should be evaluated before procedures

Original language description

Every year, millions of people undergo percutaneous coronary intervention (PCI) with intracoronary stent implantation. A patient from the PRAGUE-8 trial (Optimal pre-PCI clopidogrel loading: 600 mg before every coronary angiography vs. 600 mg in the cath-lab only for PCI patients) is described who suffered from acute stent thrombosis. This patient did not have any relevant inhibition of platelet activation even after the 600 mg dose of clopidogrel. Dose uptitration would have been ineffective. New P2Y12receptor inhibitors are desperately needed. In the light of recently published data, the use of prasugrel may be considered as an alternative.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FA - Cardiovascular diseases including cardio-surgery

OECD FORD branch

—

Project

—

Continuities

Z - Vyzkumny zamer (s odkazem do CEZ)

Publication year

2009

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Thrombosis Journal

ISSN

1477-9560

e-ISSN

—

Volume of the periodical

7

Issue of the periodical within the volume

1, May 19

Country of publishing house

GB - UNITED KINGDOM

Number of pages

7

Pages from-to

—

UT code for WoS article

—

EID of the result in the Scopus database

—